Works matching DE "DIHYDROERGOTAMINE"

Results: 64

Tolerability of repetitive dihydroergotamine infusions paired with an adjustment in preventive treatment strategy in chronic headache disorders in children and youth.

Published in:

Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-025-02035-x

By:

Pavitt, Sara;
Morris, Cynthia;
Shin, Lauren;
Jones, Andrew;
Vayngortin, Beata;
Zorrilla, Natalia;
Jin, Chengshi;
Allen, Isabel;
Gelfand, Amy A.

Publication type:

Article

Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.

Published in:

Journal of Headache & Pain, 2018, v. 19, n. 1, p. 1, doi. 10.1186/s10194-018-0869-8

By:

Lozano-Cuenca, Jair;
Villalón, Carlos M.;
González-Hernández, Abimael;
Marichal-Cancino, Bruno A.;
MaassenVanDenBrink, Antoinette

Publication type:

Article

The role of α- and α-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats.

Published in:

Journal of Headache & Pain, 2017, v. 18, n. 1, p. 1, doi. 10.1186/s10194-017-0812-4

By:

Rivera-Mancilla, Eduardo;
Avilés-Rosas, Victor;
Manrique-Maldonado, Guadalupe;
Altamirano-Espinoza, Alain;
Villanueva-Castillo, Belinda;
MaassenVanDenBrink, Antoinette;
Villalón, Carlos

Publication type:

Article

Identification of Anti-HIV/Migraine Drugs as Potential Inhibitors of SARS-Cov2 Main Protease Using in Silico Assessments.

Published in:

Journal of Inflammatory Diseases, 2021, v. 25, n. 3, p. 153, doi. 10.32598/JQUMS.25.3.1

By:

Shariatifar, Hanifeh;
Hooshmand, Amir;
Gheibi, Nematollah;
Farasat, Alireza

Publication type:

Article

Migraines in Women: Current Evidence for Management of Episodic and Chronic Migraines.

Published in:

Journal of Midwifery & Women's Health, 2017, v. 62, n. 3, p. 270, doi. 10.1111/jmwh.12626

By:

Deneris, Angela;
Rosati Allen, Peggy;
Hart Hayes, Emily;
Latendresse, Gwen

Publication type:

Article

Acute Treatment of Pediatric Migraine.

Published in:

Pediatric Emergency Medicine Reports, 2019, v. 24, n. 4, p. 0

By:

AHC MEDIA

Publication type:

Article

New Drugs & Indications for 2021: The Year in Review.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2022, v. 60, n. 1, p. 5, doi. 10.3928/02793695-20211129-79
Publication type:: Article

Dihydroergotamine (DHE) - Is there a place for its use?

Published in:

Journal of Pre-Clinical & Clinical Research, 2018, v. 12, n. 4, p. 149, doi. 10.26444/jpccr/99878

By:

Piechal, Agnieszka;
Blecharz-Klin, Kamilla;
Mirowska-Guzel, Dagmara

Publication type:

Article

CNS active ergot alkaloid dihydro derivatives: tritium labelling and characterization.

Published in:

Journal of Radioanalytical & Nuclear Chemistry, 2016, v. 310, n. 2, p. 823, doi. 10.1007/s10967-016-4815-4

By:

Egan, Judith;
Nugent, Richard;
Filer, Crist

Publication type:

Article

Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis.

Published in:

Journal of Headache & Pain, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s10194-023-01662-6

By:

Li, Guanglu;
Duan, Shaojie;
Zhu, Tiantian;
Ren, Zhiying;
Xia, Hui;
Wang, Ziyao;
Liu, Lei;
Liu, Zunjing

Publication type:

Article

Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure.

Published in:

Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01519-4

By:

Tepper, Stewart J.;
Ailani, Jessica;
Ray, Sutapa;
Hirman, Joe;
Shrewsbury, Stephen B.;
Aurora, Sheena K.

Publication type:

Article

Exacerbation of SUNCT and SUNA syndromes during intravenous dihydroergotamine treatment: A case series.

Published in:

2015

By:

Lambru, Giorgio;
Shanahan, Paul;
Matharu, Manjit

Publication type:

journal article

Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein.

Published in:

Cephalalgia, 2015, v. 35, n. 2, p. 182, doi. 10.1177/0333102414544977

By:

Labruijere, Sieneke;
Chan, Kayi Y;
de Vries, René;
van den Bogaerdt, Antoon J;
Dirven, Clemens M;
Danser, AH Jan;
Kori, Shashidhar H;
MaassenVanDenBrink, Antoinette

Publication type:

Article

Sumatriptan by injection.

Published in:

2001

By:

Ferrari, M D

Publication type:

journal article

Cerebral Venous Thrombosis with Migraine-Like Headache and the Trigeminovascular System.

Published in:

Case Reports in Neurological Medicine, 2016, p. 1, doi. 10.1155/2016/2059749

By:

Nascimento, Fábio A.;
Sória, Marília Grando;
Rizelio, Vanessa;
Kowacs, Pedro A.

Publication type:

Article

Extracellular Alkaline Lipase from a Novel Fungus Curvularia sp. DHE 5: Optimisation of Physicochemical Parameters, Partial Purification and Characterisation.

Published in:

Food Technology & Biotechnology, 2017, v. 55, n. 2, p. 206, doi. 10.17113/ftb.55.02.17.4958

By:

El-Ghonemy, Dina Helmy;
El-Gamal, Mamdouh S.;
Tantawy, Amir Elsayed;
Ali, Thanaa Hamed

Publication type:

Article

The PROMISE study: PROphylaxis of MIgraine with SEglor (dihydroergotamine mesilate) in French primary care.

Published in:

2004

By:

Pradalier, André;
Lantéri-Minet, Michel;
Géraud, Gilles;
Allain, Hervé;
Lucas, Christian;
Delgado, Antonio;
Pradalier, André;
Lantéri-Minet, Michel;
Géraud, Gilles;
Allain, Hervé

Publication type:

journal article

Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine.

Published in:

2016

By:

Schankin, Christoph J.;
Maniyar, Farooq H.;
Youngho Seo;
Shashidar Kori;
Eller, Michael;
Chou, Denise E.;
Blecha, Joseph;
Murphy, Stephanie T.;
Hawkins, Randall A.;
Sprenger, Till;
VanBrocklin, Henry F.;
Goadsby, Peter J.;
Seo, Youngho;
Kori, Shashidar

Publication type:

journal article

Is the blood-brain barrier differentially affected by different variants of migraine?

Published in:

2016

By:

Dreier, Jens P.

Publication type:

journal article

Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy.

Published in:

2003

By:

Schaerlinger, B;
Hickel, P;
Etienne, N;
Guesnier, L;
Maroteaux, L

Publication type:

journal article

Short Term Oral Methylergonovine Maleate Prophylaxis for Status Migrainosus. Case Series and Review of Literature.

Published in:

Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00201

By:

Haque, Najiya;
Tariq, Nauman

Publication type:

Article

Enhancing Intranasal Delivery and Bioavailability of Dihydroergotamine Utilizing Chitosan Nanoparticles.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2023, p. 1, doi. 10.1155/2023/2284371

By:

Alastal, Ahmed;
Kwaik, Amani D. Abu;
Malkawi, Azzam A.;
Baltzley, Sarah;
Al-Ghananeem, Abeer M.

Publication type:

Article

Practical approaches to migraine management.

Published in:

2002

By:

Diamond, S.;
Wenzel, R.;
Diamond, Seymour;
Wenzel, Richard

Publication type:

journal article

Dihydroergotamine-erythromycin-induced ergotism.

Published in:

1988

By:

Leroy, F;
Asseman, P;
Pruvost, P;
Adnet, P;
Lacroix, D;
Thery, C

Publication type:

Case Study

Relationship of dihydroergotamine pharmacokinetics, clinical efficacy, and nausea—A narrative review.

Published in:

Headache: The Journal of Head & Face Pain, 2025, v. 65, n. 3, p. 527, doi. 10.1111/head.14877

By:

Lipton, Richard B.;
Kollins, John A.;
Albrecht, Detlef

Publication type:

Article

Real‐world approaches to outpatient treatment of status migrainosus: A survey study.

Published in:

Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 1040, doi. 10.1111/head.14769

By:

Robblee, Jennifer;
Orlova, Yulia Y.;
Ahn, Andrew H.;
Ali, Ashhar S.;
Birlea, Marius;
Charleston, Larry;
Singh, Niranjan N.;
Souza, Marcio Nattan P.

Publication type:

Article

Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine.

Published in:

Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 8, p. 983, doi. 10.1111/head.14669

By:

Dafer, Rima M.;
Tietjen, Gretchen E.;
Rothrock, John F.;
Vann, Robert E.;
Shrewsbury, Stephen B.;
Aurora, Sheena K.

Publication type:

Article

Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double‐blind study in healthy adults.

Published in:

Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 6, p. 643, doi. 10.1111/head.14731

By:

Bodie, Susan;
Curran, Aidan K.;
Gonzalez‐Nelson, Aaron C.;
Perry, Jason M.;
Manning, Debora C.;
Wasilewski, Margaret M.

Publication type:

Article

A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in healthy adults.

Published in:

Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 3, p. 266, doi. 10.1111/head.14685

By:

Lipton, Richard B.;
Albrecht, Detlef;
Bermudez, Maria;
Hu, Jerry;
Hussey, Elizabeth;
Levy, Jeff

Publication type:

Article

Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study.

Published in:

Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 9, p. 1251, doi. 10.1111/head.14636

By:

Wang, Victor S.;
Kosman, Justin;
Yuan, Hsiangkuo;
Lauritsen, Clinton;
Shrewsbury, Stephen;
Aurora, Sheena K.;
Hopkins, Mary;
Silberstein, Stephen

Publication type:

Article

STOP 301: A Phase 3, open‐label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD®) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients

Published in:

Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 8, p. 1214, doi. 10.1111/head.14184

By:

Smith, Timothy R.;
Winner, Paul;
Aurora, Sheena K.;
Jeleva, Maria;
Hocevar‐Trnka, Jasna;
Shrewsbury, Stephen B.

Publication type:

Article

Everything old is new again.

Published in:: 2021
Publication type:: Letter to the Editor

The status of intravenous dihydroergotamine for pediatric headache: Status migrainosus and beyond.

Published in:

Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 5, p. 698, doi. 10.1111/head.14114

By:

Greene, Kaitlin A.

Publication type:

Article

Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review.

Published in:

Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 5, p. 777, doi. 10.1111/head.14117

By:

Srouji, Rasha;
Schenkel, Sara R.;
Forbes, Peter;
Cahill, Jennifer E.

Publication type:

Article

Implementation of an Intravenous Dihydroergotamine Protocol for Refractory Migraine in Children.

Published in:

Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 8, p. 1653, doi. 10.1111/head.13937

By:

Theroux, Liana M.;
Cappa, Ryan;
Mendoza, Alyssa;
Mallawaarachchi, Indika;
Samanta, Debopam;
Goodkin, Howard P.

Publication type:

Article

A Phase 1, Randomized, Open‐Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects.

Published in:

Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 4, p. 701, doi. 10.1111/head.13737

By:

Albrecht, Detlef;
Iwashima, Mic;
Dillon, Debbie;
Harris, Stuart;
Levy, Jeff

Publication type:

Article

The Headache Pipeline: Excitement and Uncertainty.

Published in:

Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 1, p. 190, doi. 10.1111/head.13728

By:

Rapoport, Alan M.;
McAllister, Peter

Publication type:

Article

Dihydroergotamine (DHE) – Then and Now: A Narrative Review.

Published in:

Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 1, p. 40, doi. 10.1111/head.13700

By:

Silberstein, Stephen D.;
Shrewsbury, Stephen B.;
Hoekman, John

Publication type:

Article

Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol ("CAMP").

Published in:

Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 1, p. 101, doi. 10.1111/head.13685

By:

Connelly, Mark;
Sekhon, Subhjit;
Stephens, Dane;
Boorigie, Madeline;
Bickel, Jennifer

Publication type:

Article

New Daily Persistent Headache With a Thunderclap Onset.

Published in:

2019

By:

Evans, Randolph W.

Publication type:

Letter to the Editor

Getting to the Heart of the Matter: Migraine, Triptans, DHE, Ditans, CGRP Antibodies, First/Second‐Generation Gepants, and Cardiovascular Risk.

Published in:

Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 8, p. 1421, doi. 10.1111/head.13601

By:

Mathew, Paul G.;
Klein, Brad C.

Publication type:

Article

STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD®) Device, in Healthy Adult Subjects.

Published in:

Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 3, p. 394, doi. 10.1111/head.13476

By:

Shrewsbury, Stephen B.;
Jeleva, Maria;
Satterly, Kelsey H.;
Lickliter, Jason;
Hoekman, John

Publication type:

Article

Effectiveness of Oxygen and Other Acute Treatments for Cluster Headache: Results From the Cluster Headache Questionnaire, an International Survey.

Published in:

Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 2, p. 235, doi. 10.1111/head.13473

By:

Pearson, Stuart M.;
Burish, Mark J.;
Shapiro, Robert E.;
Yan, Yuanqing;
Schor, Larry I.

Publication type:

Article

The Study Design Used Was Wrong But the Conclusions Made About the Drug Were Later Found to Be Correct.

Published in:

Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 9, p. 1404, doi. 10.1111/head.12903

By:

Dahlöf, Carl

Publication type:

Article

Is the Generally Held View That Intravenous Dihydroergotamine Is Effective in Migraine Based on Wrong 'General Consensus' of One Trial? A Critical Review of the Trial and Subsequent Quotations.

Published in:

Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 9, p. 1482, doi. 10.1111/head.12904

By:

Bekan, Goran;
Tfelt‐Hansen, Peer

Publication type:

Article

How to Apply the AHS Evidence Assessment of the Acute Treatment of Migraine in Adults to your Patient with Migraine.

Published in:

Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 7, p. 1194, doi. 10.1111/head.12870

By:

Pringsheim, Tamara;
Davenport, William Jeptha;
Marmura, Michael J.;
Schwedt, Todd J.;
Silberstein, Stephen

Publication type:

Article

A retrospective analysis of triptan and dhe use for basilar and hemiplegic migraine.

Published in:

Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 5, p. 841, doi. 10.1111/head.12804

By:

Mathew, Paul G.;
Krel, Regina;
Buddhdev, Bhuvin;
Ansari, Hossein;
Joshi, Shivang G.;
Spinner, Warren D.;
Klein, Brad C.

Publication type:

Article

Pediatric Inpatient Headache Therapy: What Is Available.

Published in:

Headache: The Journal of Head & Face Pain, 2015, v. 55, n. 10, p. 1426, doi. 10.1111/head.12701

By:

Kabbouche, Marielle

Publication type:

Article

Management of Pediatric Migraine Headache in the Emergency Room and Infusion Center.

Published in:

Headache: The Journal of Head & Face Pain, 2015, v. 55, n. 10, p. 1365, doi. 10.1111/head.12694

By:

Kabbouche, Marielle

Publication type:

Article

Drug Shortages and Tipping Points.

Published in:

Headache: The Journal of Head & Face Pain, 2015, v. 55, n. 9, p. 1294, doi. 10.1111/head.12689

By:

Wenzel, Richard

Publication type:

Article